ROBERTS BRANDI (Chief Financial Officer) sold 1.4% of their position (3.01K shares) of DEFINIUM THERAPEUTICS, INC. on the open market
Open‑market sale worth $135.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/26/2026ACC: 0001193125-26-285563
Officer· Chief Financial Officer
Since Feb 2026
-3.01K
Net shares
Net seller
$135.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.01K disposed
Non-Derivative Transactions1
Common Shares
Direct
Shares
−3.01K
Price / share
$45.03
Trade value
$135.68K
% of position
1.4%
6/25/2026
212.50K→209.49K
Total
Net shares
−3.01K
Net value
-$135.68K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 6/25/2026 | S · Sale | −3.01K | $45.03 | $135.68K | 1.4% | 212.50K | 209.49K |
| Total | −3.01K | -$135.68K | ||||||
Derivative Transactions0
No derivative transactions reported